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Dengue virus (DENV) is an arboviral human pathogen transmitted through mosquito bite that infects an estimated similar to 400 million humans (similar
to 5% of the global population) annually. To date, no specific therapeutics have been developed that can prevent or treat infections resulting from this
pathogen. DENV utilizes numerous host molecules and factors for transcribing the single-stranded similar to 11 kb positive-sense RNA genome. For
example, the glycosylation machinery of the host is required for viral particles to assemble in the endoplasmic reticulum. Since a variety of host factors
seem to be utilized by the pathogens, targeting these factors may result in DENV inhibitors, and will play an important role in attenuating the rapid
emergence of other flaviviruses. Many experimental studies have yielded findings indicating that host factors facilitate infection, indicating that the focus
should be given to targeting the processes contributing to pathogenesis along with many other immune responses. Here, we provide an extensive
literature review in order to elucidate the progress made in the development of host-based approaches for DENV viral infections, focusing on host cellular
mechanisms and factors responsible for viral replication, aiming to aid the potential development of host-dependent antiviral therapeutics.
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